118 related articles for article (PubMed ID: 38493073)
21. Reply to Marc A. Furrer and Patrick Y. Wuethrich's and Francesco Montorsi, Marco Moschini, Giorgio Gandaglia, and Alberto Briganti's Letters to the Editor re: Jakob Klemm, Michael Rink, Markus Von Deimling, et al. Time-to-complication Patterns After Radical Cystectomy: A Secondary Analysis of a 30-day Morbidity Assessment Using the European Association of Urology Quality Criteria for Standardized Reporting. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.06.005.
Klemm J; Koelker M; Shariat SF; Fisch M; Vetterlein MW
Eur Urol Focus; 2023 Oct; ():. PubMed ID: 37806850
[No Abstract] [Full Text] [Related]
22. Reply to Juan Gómez Rivas, Giorgio Gandaglia, and Francesco Montorsi's Letter to the Editor re: Neal D. Shore, Joseph Renzulli, Neil E. Fleshner, et al. Enzalutamide Monotherapy vs Active Surveillance in Patients with Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial. JAMA Oncol 2022;8:1128-36.
Shore ND
Eur Urol Open Sci; 2022 Dec; 46():145-146. PubMed ID: 36420113
[No Abstract] [Full Text] [Related]
23. Re: Helena Vila-Reyes, G. Joel DeCastro, and James M. McKiernan's Letter to the Editor re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020; 77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer? Eur Urol 2021;79:e35-e36.
Panebianco V; Del Giudice F; Narumi Y; Simone G; De Berardinis E; Catto JWF
Eur Urol; 2021 Feb; 79(2):e52-e53. PubMed ID: 33261940
[No Abstract] [Full Text] [Related]
24. Reply to Francesco Montorsi, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.
Moris L; Mottet N; Wiegel T;
Eur Urol; 2020 Nov; 78(5):e193-e194. PubMed ID: 32838999
[No Abstract] [Full Text] [Related]
25. Reply to Giancarlo Marra, Marco Oderda, Paolo Gontero, and Lorenzo Richiardi's Letter to the Editor re: Jim C. Hu, Melissa Assel, Mohamad E. Allaf, et al. Transrectal Magnetic Resonance Imaging-targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.12.015.
Hu JC; Allaf ME; Vickers AJ; Schaeffer EM
Eur Urol; 2024 Apr; ():. PubMed ID: 38599991
[No Abstract] [Full Text] [Related]
26. Reply to Francesco Montorsi, Armando Stabile, Giorgio Gandaglia, and Alberto Briganti's Letter to the Editor re: K.R. Seetharam Bhat, Marcio Covas Moschovas, Marco Sandri, et al. Outcomes of Salvage Robot-assisted Radical Prostatectomy After Focal Ablation for Prostate Cancer in Comparison to Primary Robot-assisted Radical Prostatectomy: A Matched Analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.10.005: Salvage Robotic Radical Prostatectomy for Recurrence After Focal Therapy-The Truth and Consequences.
Patel V; Bhat KRS; Moschovas MC; Noel J; Rogers T
Eur Urol Focus; 2022 Nov; 8(6):1864. PubMed ID: 35219650
[No Abstract] [Full Text] [Related]
27. Reply to Yudai Ishiyama and Fumihiko Urabe's Letter to the Editor re: Kosuke Takemura, Audreylie Lemelin, Matthew S. Ernst, et al. Outcomes of Patients with Brain Metastases from Renal Cell Carcinoma Receiving First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.01.006.
Takemura K; Yuasa T; Choueiri TK; Heng DYC
Eur Urol; 2024 Mar; ():. PubMed ID: 38531704
[No Abstract] [Full Text] [Related]
28. Reply to Yunjin Bai, Yubo Yang, Yin Tang's Letter to the Editor, re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01, Study. Eur Urol 2020;77:636-43.
Bandini M; Necchi A
Eur Urol; 2020 Jun; 77(6):e159-e160. PubMed ID: 32184002
[No Abstract] [Full Text] [Related]
29. Reply to Giancarlo Marra, Armando Stabile, Paolo Gontero, Francesco Montorsi, Alberto Briganti, and Giorgio Gandaglia's Letter to the Editor re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019: A Storm in a Teacup.
Meissner VH; Gschwend JE; Heck MM
Eur Urol; 2022 May; 81(5):e117. PubMed ID: 35131117
[No Abstract] [Full Text] [Related]
30. Reply to: Antonio Andrea Grosso, Agostino Tuccio, Matteo Salvi, Daniele Paganelli, Andrea Minervini, and Fabrizio Di Maida's Letter to the Editor re: Paolo Capogrosso, Eugenio Ventimiglia, Giuseppe Fallara, et al. Holmium Laser Enucleation of the Prostate Is Associated with Complications and Sequelae Even in the Hands of an Experienced Surgeon Following Completion of the Learning Curve. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.03.018.
Capogrosso P; Ventimiglia E; Fallara G; Schifano N; Costa A; Candela L; Pellegrino F; Colandrea G; Cignoli D; De Angelis M; Belladelli F; Longoni M; Avesani G; Lanzaro F; Scattoni V; Dehò F; Salonia A; Briganti A; Montorsi F
Eur Urol Focus; 2024 Jan; 10(1):207-208. PubMed ID: 37442724
[No Abstract] [Full Text] [Related]
31. Reply to Ozan Cem Guler and Cem Onal's Letter to the Editor re: Jian Pan, Yu Wei, Tingwei Zhang, et al. Stereotactic Radiotherapy for Lesions Detected via
Pan J; Wang B; Zhu Y
Eur Urol Oncol; 2022 Aug; 5(4):479. PubMed ID: 35710620
[No Abstract] [Full Text] [Related]
32. Re: Guillaume Ploussard, Eric Barret, Gaëlle Fiard, et al. Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsies for Prostate Cancer Diagnosis: Final Results of the Randomized PERFECT trial (CCAFU-PR1). Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2024.01.019.
Lin FX; Yu Y; Xu ZP
Eur Urol Oncol; 2024 May; ():. PubMed ID: 38772750
[No Abstract] [Full Text] [Related]
33. Reply to Mengda Zhang and Long Wang's Letter to the Editor re: Francesco Porpiglia, Enrico Checcucci, Daniele Amparore, et al. Three-dimensional Augmented Reality Robot-assisted Partial Nephrectomy in Case of Complex Tumours (PADUA ≥ 10): A New Intraoperative Tool Overcoming the Ultrasound Guidance. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.11.024.
Amparore D; Checcucci E; Fiori C; Porpiglia F
Eur Urol; 2020 Jun; 77(6):e163-e164. PubMed ID: 32279902
[No Abstract] [Full Text] [Related]
34. Reply to Feng Qi, Zicheng Xu, and Qing Zou's Letter to the Editor re: Andrea Loehr, Arif Hussain, Akash Patnaik, et al. Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.09.010.
Loehr A; Chowdhury S; Abida W
Eur Urol; 2023 Mar; 83(3):e78. PubMed ID: 36623951
[No Abstract] [Full Text] [Related]
35. Reply to Luca Sarchi, Maria Chiara Sighinolfi, Simone Assumma, et al.'s Letter to Editor re: Carlo A. Bravi, Marco Paciotti, Eleonora Balestrazzi, et al. Outcomes of Robot-assisted Radical Prostatectomy with the Hugo RAS Surgical System: Initial Experience at a High-volume Robotic Center. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.01.008.
Bravi CA; Mottrie A
Eur Urol Focus; 2023 Sep; 9(5):843. PubMed ID: 36898944
[No Abstract] [Full Text] [Related]
36. Reply to Fumihiko Urabe, Takashi Yoshioka, and Takahiro Kimura's Letter to the Editor re: Felix Seelemeyer, David Pfister, Robert Pappesch, Sabine Merkelbach-Bruse, Pia Paffenholz and Axel Heidenreich. Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.10.021.
Seelemeyer F; Pfister D; Pappesch R; Merkelbach-Bruse S; Paffenholz P; Heidenreich A
Eur Urol Oncol; 2024 Apr; 7(2):306. PubMed ID: 38238223
[No Abstract] [Full Text] [Related]
37. Re: Karim A. Touijer, Daniel D. Sjoberg, Nicole Benfante, et al. Limited Versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2021.03.006.
Yang B; Yang G; Yao X
Eur Urol Oncol; 2021 Oct; 4(5):852-853. PubMed ID: 34535419
[No Abstract] [Full Text] [Related]
38. Reply to Jinna Yao, Henry C.C. Pleass, and Howard M.H. Lau's Letter to the Editor re: Andrea Gallioli, Angelo Territo, Romain Boissier, et al. Learning Curve in Robot-assisted Kidney Transplantation: Results from the European Robotic Urological Society Working Group. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.12.008.
Gallioli A; Territo A; Breda A
Eur Urol; 2020 Jun; 77(6):e166-e167. PubMed ID: 32291108
[No Abstract] [Full Text] [Related]
39. Re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020;77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer?
Vila-Reyes H; DeCastro GJ; McKiernan JM
Eur Urol; 2021 Jan; 79(1):e35-e36. PubMed ID: 32829975
[No Abstract] [Full Text] [Related]
40. Reply to Francesco Massari, Vincenzo Di Nunno, and Andrea Ardizzoni's Letter to the Editor re: Robert J. Motzer, Alain Ravaud, Jean-Jacques Patard, et al. Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results. Eur Urol 2018;73:62-8.
Motzer RJ; Escudier B; Ravaud A
Eur Urol; 2018 Mar; 73(3):e73. PubMed ID: 29126652
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
